rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2011-5-30
|
pubmed:abstractText |
Not all patients treated on the basis of PET-proven viability benefit from revascularization. Myocardial perfusion reserve (MPR) predicts survival in patients not undergoing revascularization. In the present study, we investigated whether MPR is related to survival in ischemic heart disease (IHD) patients after a PET-driven intervention.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1535-5667
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
873-9
|
pubmed:meshHeading |
pubmed-meshheading:21571798-Aged,
pubmed-meshheading:21571798-Ammonia,
pubmed-meshheading:21571798-Capillaries,
pubmed-meshheading:21571798-Coronary Artery Disease,
pubmed-meshheading:21571798-Coronary Circulation,
pubmed-meshheading:21571798-Dipyridamole,
pubmed-meshheading:21571798-Endpoint Determination,
pubmed-meshheading:21571798-Exercise Test,
pubmed-meshheading:21571798-Female,
pubmed-meshheading:21571798-Fluorodeoxyglucose F18,
pubmed-meshheading:21571798-Heart,
pubmed-meshheading:21571798-Hemodynamics,
pubmed-meshheading:21571798-Humans,
pubmed-meshheading:21571798-Kaplan-Meier Estimate,
pubmed-meshheading:21571798-Male,
pubmed-meshheading:21571798-Middle Aged,
pubmed-meshheading:21571798-Myocardial Revascularization,
pubmed-meshheading:21571798-Myocardial Stunning,
pubmed-meshheading:21571798-Perfusion,
pubmed-meshheading:21571798-Positron-Emission Tomography,
pubmed-meshheading:21571798-Prognosis,
pubmed-meshheading:21571798-Radiopharmaceuticals,
pubmed-meshheading:21571798-Recovery of Function,
pubmed-meshheading:21571798-Surgery, Computer-Assisted,
pubmed-meshheading:21571798-Survival Analysis,
pubmed-meshheading:21571798-Vasodilator Agents
|
pubmed:year |
2011
|
pubmed:articleTitle |
Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
|
pubmed:affiliation |
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.
|
pubmed:publicationType |
Journal Article
|